Cost-effectiveness of antiretroviral therapy expansion strategies in Vietnam
GHDx Entry last modified on: Apr 10, 2023
Health care economics
Dataset Records for Health care economics
Displaying 151 - 200 of 258
Senegal National AIDS Control Council Annual Report 2015
Rapport Annuel 2015
Report:
Epi surveillance - Subnationally representative
Burkina Faso National Health Accounts 2005
Rapport sur les Comptes Nationaux de la Santé - 2005
Pakistan National Health Accounts 2005-2006
GHDx Entry last modified on: Nov 6, 2018
Senegal National AIDS Control Council Annual Report 2016
Rapport Annuel 2016
Report:
Epi surveillance - Subnationally representative
Health and economic impact of rotavirus vaccination in GAVI-eligible countries
GHDx Entry last modified on: Jan 28, 2023
Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study
GHDx Entry last modified on: Apr 10, 2023
Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France
GHDx Entry last modified on: Jan 28, 2023
Estimated impact and cost-effectiveness of rotavirus vaccination in India: effects of geographic and economic disparities
GHDx Entry last modified on: Jan 28, 2023
Burkina Faso National Health Accounts 2004
Construction des Comptes Nationaux de la Santé pour 2004
Cost-effectiveness of Rotavirus vaccination in Vietnam
GHDx Entry last modified on: Jan 28, 2023
India National Health Accounts 2004-2005
Report:
Nationally representative - Subnationally representative
Argentina Register of Chronic Dialysis 2004-2005
Registro Argentino de Diálisis Crónica 04/05
Disease registry:
Subnationally representative
Saint Vincent and the Grenadines National Health Accounts, HIV/AIDs Subaccounts 2004
GHDx Entry last modified on: Jan 7, 2019
Vietnam National Health Accounts, HIV/AIDs Subaccounts 2004
GHDx Entry last modified on: Sep 29, 2023
The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands
GHDx Entry last modified on: Jan 28, 2023
Ethiopia National Health Accounts 2004-2005
GHDx Entry last modified on: Nov 15, 2023
Mozambique National Health Accounts 2004-2006
GHDx Entry last modified on: Feb 5, 2024
Burkina Faso National Health Accounts 2003
Construction des Comptes Nationaux de la Santé pour 2003
Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana
GHDx Entry last modified on: Jan 28, 2023
Tanzania National Health Accounts 2002-2003, 2005-2006
GHDx Entry last modified on: Jan 7, 2019
Cape Verde Statistical Report 2014
República de Cabo Verde Relatório Estatístico 2014
Report:
Epi surveillance - Financial - Subnationally representative
Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam
GHDx Entry last modified on: Jan 28, 2023
Ukraine National Health Accounts 2003-2004
GHDx Entry last modified on: Jan 7, 2019
United States Health Expenditure by State, Payer, and Type of Care, 2003-2019
Estimate:
Subnationally representative
Yemen National Health Accounts 2003
GHDx Entry last modified on: Jan 7, 2019
Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule
GHDx Entry last modified on: Jan 28, 2023
Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries
GHDx Entry last modified on: Jan 28, 2023
Zambia National Health Accounts 2003-2006
GHDx Entry last modified on: Jan 7, 2019
Economic impact of a rotavirus vaccine in Brazil
GHDx Entry last modified on: Jan 28, 2023
Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya
GHDx Entry last modified on: Jan 28, 2023
Albania National Health Accounts 2003
GHDx Entry last modified on: Nov 6, 2018
Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness
GHDx Entry last modified on: Jan 28, 2023
Niger National Health Accounts 2002-2003
Comptes Nationaux de Santé Exercise 2002-2003
Report:
Financial
Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination
GHDx Entry last modified on: Jan 28, 2023
Zambia National Health Accounts 2002
GHDx Entry last modified on: Jan 7, 2019
Zambia National Health Accounts 2002-2004
GHDx Entry last modified on: Nov 6, 2018
Socio-economic modelling of rotavirus vaccination in Castilla y Leon, Spain
GHDx Entry last modified on: Jan 31, 2024
Ghana National Health Accounts 2002
GHDx Entry last modified on: Nov 15, 2023
Gambia National Health Accounts 2002-2004
GHDx Entry last modified on: Nov 15, 2023
Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children 5 years of age in Taiwan
GHDx Entry last modified on: Jan 28, 2023
Egypt National Health Accounts 2001-2002
GHDx Entry last modified on: Jan 7, 2019
India National Health Accounts 2001-2002
Report:
Nationally representative - Subnationally representative
Kenya National Health Accounts 2001-2002
GHDx Entry last modified on: Jan 7, 2019
Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: a model-based evaluation
GHDx Entry last modified on: Jan 31, 2024
Cost-effectiveness of childhood rotavirus vaccination in Germany
GHDx Entry last modified on: Jan 28, 2023
Georgia National Health Accounts 2001-2003
GHDx Entry last modified on: Jan 7, 2019
Georgia National Health Accounts: Tuberculosis Subaccounts 2001-2005
The Calculation of Funds Spent by the State and Donors on TB Treatment and Prevention
Namibia National Health Accounts 2001-2007
GHDx Entry last modified on: Oct 22, 2023
Subscribe